Rox Resources Limited (RXL)

Overview

The fund is designed to offer investment opportunities in the healthcare and life sciences sectors, targeting daily returns that align with its Daily Target. Managed by ProShare Advisors, the fund operates with a focus on financial instruments believed to synergistically create the desired daily outcome. Unlike diversified funds, it maintains a non-diversified status, concentrating its investments in the specific industries of health care equipment & supplies, health care providers & services, health care technology, biotechnology, pharmaceuticals, and life sciences tools & services. This strategic focus is aimed at investors seeking exposure to these dynamic sectors through a specialized investment vehicle.

Products and Services

• Health Care Equipment & Supplies

  Investment in companies manufacturing medical equipment and supplies. This includes a wide range of products necessary for the diagnosis, treatment, and monitoring of diseases and conditions, from surgical and medical instruments to the supplies used in medical settings.

• Health Care Providers & Services

  Funding entities that deliver medical services directly to patients. This category encompasses a broad spectrum of providers, such as hospitals, clinics, nursing homes, and diagnostic labs, offering investment opportunities in the delivery side of healthcare.

• Health Care Technology

  Investment in companies that are at the forefront of technological innovation in healthcare. These include businesses developing or deploying health informatics, medical software, and online health services, aiming to improve efficiencies, patient care, and the overall health system.

• Biotechnology

  Capital allocation toward firms engaged in the research and development, manufacturing, and distribution of biotechnological products. These companies work on the development of novel drugs and therapies that harness biological systems for medical treatment and diagnosis.

• Pharmaceuticals

  Investment in companies involved in the creation, production, and marketing of medications. This segment focuses on firms that have a significant role in the pharmaceutical industry, from the development of new drugs to their distribution and sales.

• Life Sciences Tools & Services

  Fund allocations to companies providing tools, services, and solutions for the life sciences industry. This includes organizations offering specialized equipment, reagents, and services critical for research and development activities in the fields of biotechnology and pharmaceuticals.